About
Discover why industry leaders, investors and institutions rely on MEDraysintell.
Founded in 2013 by Paul-Emmanuel Goethals and Richard Zimmermann, MEDraysintell leverages over decades of combined expertise in medical applications of ionising radiations.
MEDraysintell :
- provides the most comprehensive intelligence on medical technologies involving radiation, delivering more than 5,000 pages of detailed reports and directories.
- empowers clients worldwide to navigate market trends, competitive landscapes, M&A opportunities, and innovation strategies.
- actively engages in major industry events and international congresses, with direct contributions in presentations and panel discussions. This strong presence ensures we remain at the forefront of industry developments and continuously expand our global network.
- support companies, investors, consultants, and research institutions with tailored, high-value analyses designed to meet their specific needs.
Since 2024, MEDraysintell has been part of NucAdvisor, a nuclear consulting firm within Soletanche Freyssinet (VINCI Group).
Why should you trust us ?
What sets us apart
While many consulting firms spread their focus across numerous industries, at MEDraysintell, we are fully dedicated to nuclear medicine : it's our core expertise and the foundation of everything we do. Each project is the result of in-depth analysis carried out by a specialized team, in close relation with the industry.
Experience-driven knowledge
Our expertise is the result of years of dedicated work, rooted in a singular focus on the nuclear medicine ecosystem. It has been built progressively, through the rigorous efforts of our team to collect, structure, and analyze critical information : without relying on automated tools or artificial intelligence. This know-how is human, experienced, and field-driven. Over time, we have developed a deep and nuanced understanding of the sector: from industrial strategies and clinical development pipelines to marketed radiopharmaceuticals, regulatory frameworks, and the evolving radionuclide supply chain. Our continuous monitoring of key stakeholders, clinical studies, and production infrastructures allows us to anticipate market shifts and identify emerging trends with precision. This expertise has not been assembled overnight, but rather cultivated through consistent engagement and sustained involvement at the heart of the field. It reflects not only a knowledge base, but a long-standing commitment to the domain. Today, MEDraysintell stands as the only organization offering such dedicated, in-depth intelligence in nuclear medicine — reinforced by strong, long-established ties with industry leaders worldwide.
Understand both global and local dynamics
Our expertise spans international boundaries, supported by a team capable of managing projects across Europe, the USA, and beyond. Drawing on a strong global network, we collaborate closely with local specialists as needed to deliver accurate, context-driven insights. Our comprehensive market coverage spans all key players worldwide, granting us a unique perspective that integrates local, regional, and international challenges. This multi-level understanding enables us to deliver nuanced intelligence tailored to the complexities of each market and project. By combining global vision with local expertise, we provide our clients with informed, strategic guidance that drives impactful decisions in the dynamic landscape of nuclear medicine and related fields
Adapting our expertise to your needs
We provide specialized intelligence services to a diverse range of organizations within the nuclear medicine sector, each with distinct strategic priorities. For manufacturers and R&D actors driving innovation, we deliver market insights and competitive intelligence to support product development and strategic planning. Investors rely on our financial and market analyses to guide investment decisions, while consulting firms involved in M&A benefit from our thorough due diligence support and sector expertise. In addition, we collaborate with governmental agencies and public institutions responsible for developing national and regional healthcare strategies. This wide-ranging client portfolio reflects the breadth and depth of our expertise, enabling us to provide tailored, high-quality insights adapted to varied needs and objectives. Through these multifaceted engagements, we support our clients in navigating the complexities of the nuclear medicine ecosystem with clarity and precision.
Our expertise is the result of years of dedicated work, rooted in a singular focus on the nuclear medicine ecosystem. It has been built progressively, through the rigorous efforts of our team to collect, structure, and analyze critical information : without relying on automated tools or artificial intelligence. This know-how is human, experienced, and field-driven. Over time, we have developed a deep and nuanced understanding of the sector: from industrial strategies and clinical development pipelines to marketed radiopharmaceuticals, regulatory frameworks, and the evolving radionuclide supply chain. Our continuous monitoring of key stakeholders, clinical studies, and production infrastructures allows us to anticipate market shifts and identify emerging trends with precision. This expertise has not been assembled overnight, but rather cultivated through consistent engagement and sustained involvement at the heart of the field. It reflects not only a knowledge base, but a long-standing commitment to the domain. Today, MEDraysintell stands as the only organization offering such dedicated, in-depth intelligence in nuclear medicine — reinforced by strong, long-established ties with industry leaders worldwide.
Our expertise spans international boundaries, supported by a team capable of managing projects across Europe, the USA, and beyond. Drawing on a strong global network, we collaborate closely with local specialists as needed to deliver accurate, context-driven insights. Our comprehensive market coverage spans all key players worldwide, granting us a unique perspective that integrates local, regional, and international challenges. This multi-level understanding enables us to deliver nuanced intelligence tailored to the complexities of each market and project. By combining global vision with local expertise, we provide our clients with informed, strategic guidance that drives impactful decisions in the dynamic landscape of nuclear medicine and related fields
We provide specialized intelligence services to a diverse range of organizations within the nuclear medicine sector, each with distinct strategic priorities. For manufacturers and R&D actors driving innovation, we deliver market insights and competitive intelligence to support product development and strategic planning. Investors rely on our financial and market analyses to guide investment decisions, while consulting firms involved in M&A benefit from our thorough due diligence support and sector expertise. In addition, we collaborate with governmental agencies and public institutions responsible for developing national and regional healthcare strategies. This wide-ranging client portfolio reflects the breadth and depth of our expertise, enabling us to provide tailored, high-quality insights adapted to varied needs and objectives. Through these multifaceted engagements, we support our clients in navigating the complexities of the nuclear medicine ecosystem with clarity and precision.
our team
Team members
Nicolas MARIO
Head of Nuclear Medicine BU
Fields of expertise :
- Radionuclide supply chains
- Research reactors
- Medical cyclotrons
- Stable isotopes enrichment
Dr. Vincent BRECHIN
Head of Medical & Science
Fields of expertise :
- Radiopharmaceuticals
- R&D, clinical development
- Oncology
- Biotech & start-up
Dr. Richard ZIMMERMANN
CONSULTANT
Fields of expertise :
- Radiopharmaceuticals development
- Mergers & Acquisitions
- Patient advocate
- Entrepreneurship
Paul-Emmanuel GOETHALS
CONSULTANT
Fields of expertise :
- Cyclotron
- Proton therapy
- Marketing
- Market competition
Andre KOLMAYER
CONSULTANT
Fields of expertise :
- Nuclear industry
- M&A
- R&D, irradiation
- Strategy
Dr. Jakub KOPYCINSKI
CONSULTANT
Fields of expertise :
- Neutronics
- Radiation protection
- R&D, nuclear physics
- Audit
Aziza DUSSAULT
Marketing & Communications Manager
Fields of expertise :
- Marketing
- Communication
- Project management
Mizué CILOTE
office manager
Fields of expertise :
- Financial
- Administrative
Know more
With over 20 years of experience across government institutions and multinational corporations in Japan, England, and France, Mizue is primarily responsible for managing administrative and financial tasks.
Currently an Office Manager at NucAdvisor, she has previously held similar roles at Mazars, Bank of Tokyo Mitsubishi and Japanese Embassy, where she played a key role in setting up their French branch. Highly skilled in administrative coordination and process optimization, Mizue consistently demonstrates her ability to thrive in diverse and challenging work environments.
our team
Team members
Nicolas MARIO
Head of Nuclear Medicine BU
Fields of expertise :
- Radionuclide supply chains
- Research reactors
- Medical cyclotrons
- Stable isotopes enrichment
Know more
Nicolas Mario is an experienced engineer specialised in nuclear medicine. He joined the MEDraysintell team following its integration into NucAdvisor in 2024. He has 13 years of experience in the radionuclide manufacturing industry, acquired through involvement in new build manufacturing projects worldwide (in Jordan, the
Netherlands, South Africa, Bolivia, etc.) and consulting projects for public and private stakeholders, including industrial players across the entire supply chains, such as Curium, Urenco, Blue Earth Therapeutics. As Head of Market & Supply, Nicolas Mario is a trusted advisor who carries out a range of studies for public and private stakeholders. His expertise in feasibility studies, optioneering studies, technology assessments, and market research is highly regarded. Nicolas is currently following an executive MBA program specialized in Healthcare Innovation & Technology at EDHEC Business School in Paris.
Dr. Vincent BRECHIN
Head of Medical & Science
Fields of expertise :
- Radiopharmaceuticals
- R&D, clinical development
- Oncology
- Biotech & start-up
Know more
Dr. Vincent Brechin is a global medical scientist and industry expert, holding a PhD in Medical Sciences from the University of Tokyo, along with advanced research credentials from the Mount Sinai School of Medicine in New York City and the University of Lyon. In 2024, Dr. Brechin joined NucAdvisor-MEDraysintell as Head of Medical & Science, where he delivers strategic consulting in nuclear medicine, comprehensive audits, technological surveillance, and in-depth market analysis. His work extends to advanced database management, offering data-driven insights that support business decisions and market positioning.
With over a decade of leadership in laboratory research, management, and technology-driven innovation, Dr. Brechin has built a strong specialization in oncology, RNA therapeutics, and the science of aging. His deep expertise in cutting- edge medical research directly informs his contributions to the NucAdvisor- MEDraysintell report, where he provides critical analysis on emerging medical technologies and market trends, helping clients navigate complex scientific landscapes and capitalize on growth opportunities.
Dr. Richard ZIMMERMANN
CONSULTANT
Fields of expertise :
- Radiopharmaceuticals development
- Mergers & Acquisitions
- Patient advocate
- Entrepreneurship
Know more
Dr. Richard Zimmermann founded Chrysalium Consulting in 2012 and MEDraysintell in 2013. He is a chemistry engineer, with a PhD degree in organic chemistry followed by a post-doctoral at Georgetown University, Washington, DC.
He has 15 years of experience in research laboratories of conventional pharmaceutical companies (Beecham, Solvay Pharmaceuticals) in France, Germany and the Netherlands. And over 25 years’ experience in the radiopharmaceutical industry as Head of Research & Development and business development (CIS bio, Schering Pharma, IBA Molecular).
He is the owner of Chrysalium Consulting, Co-founder of Global Morpho Pharma, Founder and President of the Oncidium Foundation, Co-founder of rad4med.be. He was involved in the creation of Telix Pharmaceuticals Ltd., and former President of Medisystem and ANMI. He is presently president of Posifit, which is the principal member of the Nancyclotep GIE, and he is the initiator of the Protherium group (CDMO/CMO unit).
Paul-Emmanuel GOETHALS
CONSULTANT
Fields of expertise :
- Cyclotron
- Proton therapy
- Marketing
- Market competition
Know more
Paul-Emmanuel Goethals founded CSIntell in 2012 followed by MEDraysintell in 2013. He has 36 years of experience in consulting, business development- intelligence and investor relations with a unique understanding of the medical and healthcare markets, especially in Radiotherapy, Radiopharmacy. Over the years, he has delivered numerous in-depth market reports with company profiles, consistently earning the full satisfaction of his clients. Paul-Emmanuel holds an MBA from the University of Dallas and is a member of SCIP (Strategic and Competitive Intelligence Professionals, Texas, USA).
Prior founding MEDraysintell and CSIntell, Paul-Emmanuel was Vice President Business Development & Capital Markets and Special Counsel to the CEO at Eckert & Ziegler Group; Director Corporate Business Development & Investor Relations at IBA; Project Manager at Strategic Analysis Inc.; Finance Director & Board member at Evening Group SA, and Marketing Specialist & Product Management at Chemviron Carbon.
Andre KOLMAYER
CONSULTANT
Fields of expertise :
- Nuclear industry
- M&A
- R&D, irradiation
- Strategy
Know more
André Kolmayer holds an MSc in Electrical Engineering, an MSc in Nuclear Engineering,
and an Executive MBA, with a 45-year background in the Nuclear sector. His experience gained in industrial companies extends from nuclear engineering (fuel, core and reactor physics, systems engineering and design, licensing, emergency preparedness, decommissioning), to executive positions (large projects, manufacturing facilities,
business unit, corporate procurement and strategy). As a consultant, he now performs due diligence, optioneering studies, market analyses, business cases, and cost estimations for investors, industry and institutions. For 10 years, he has focused particularly on questions related to medical isotopes.
Dr. Jakub KOPYCINSKI
CONSULTANT
Fields of expertise :
- Neutronics
- Radiation protection
- R&D, nuclear physics
- Audit
Know more
Jakub is a consultant with a background in nuclear and quantum physics.
Before joining the NucAdvisor team, he graduated from the Warsaw University of Technology (MSc in Nuclear Physics and Technology) and completed a PhD at the Center for Theoretical Physics in Warsaw.
Now, he focuses on the small and modular reactor market and provides in-depth assistance in implementing decarbonized energy sources for the various market players. He is supporting the MEDraysintell team thanks to his deep knowledge of radionuclides global market.
Aziza DUSSAULT
Marketing & Communications Manager
Fields of expertise :
- Marketing
- Communication
- Project management
Know more
Aziza leads the organization’s digital strategy, managing social media and content creation.
She also coordinates events and exhibitions and supports the team in business development.
Her experience in Hong Kong on marketing and communication projects strengthened her ability to work in multicultural environments.
Mizué CILOTE
office manager
Fields of expertise :
- Financial
- Administrative
Know more
With over 20 years of experience across government institutions and multinational corporations in Japan, England, and France, Mizue is primarily responsible for managing administrative and financial tasks.
Currently an Office Manager at NucAdvisor, she has previously held similar roles at Mazars, Bank of Tokyo Mitsubishi and Japanese Embassy, where she played a key role in setting up their French branch. Highly skilled in administrative coordination and process optimization, Mizue consistently demonstrates her ability to thrive in diverse and challenging work environments.
Subscribe Our Newsletter
Subscribe to Keep Up to Date with Everything
Support
MEDraysintell supports the Oncidium foundation
Who they are
The Oncidium Foundation is a non-profit organization dedicated to promoting radiotheranostics, an innovative cancer treatment within nuclear medicine. Its mission is to raise awareness and improve global access to these life-saving therapies. By connecting patients, healthcare professionals, and institutions, the foundation works to accelerate the adoption of radiotheranostics and support its development as a powerful tool in cancer care.
We Support the Oncidium Foundation
There are many variations of passages of We are proud to support the Oncidium Foundation in its mission to advance Radiotheranostics and improve access to innovative cancer treatments worldwide. Their work aligns with our values of promoting progress in nuclear healthcare. By contributing to their efforts, we help raise awareness and encourage the adoption of these promising therapies, bringing hope to patients and driving change in the future of cancer care.
Support
MEDraysintell supports the Oncidium foundation
Who they are
The Oncidium Foundation is a non-profit organization dedicated to promoting radiotheranostics, an innovative cancer treatment within nuclear medicine. Its mission is to raise awareness and improve global access to these life-saving therapies. By connecting patients, healthcare professionals, and institutions, the foundation works to accelerate the adoption of radiotheranostics and support its development as a powerful tool in cancer care.
We Support the Oncidium Foundation
There are many variations of passages of We are proud to support the Oncidium Foundation in its mission to advance Radiotheranostics and improve access to innovative cancer treatments worldwide. Their work aligns with our values of promoting progress in nuclear healthcare. By contributing to their efforts, we help raise awareness and encourage the adoption of these promising therapies, bringing hope to patients and driving change in the future of cancer care.
0
+
Global customers
0
First Edition of our report
0
+
Radiopharmaceuticals monitored in our report
0
+